Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

May 2009; Volume 50,Issue Suppl 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aboagye, Eric O.

    1. You have access
      Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
      Kaiyumars B. Contractor and Eric O. Aboagye
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 97S-105S; DOI: https://doi.org/10.2967/jnumed.108.057273
  2. Avril, Norbert

    1. You have access
      Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240

B

  1. Barrington, Sally F.

    1. You have access
      PET/CT for Therapy Response Assessment in Lymphoma
      Martin Hutchings and Sally F. Barrington
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 21S-30S; DOI: https://doi.org/10.2967/jnumed.108.057190
  2. Boellaard, Ronald

    1. You have access
      Standards for PET Image Acquisition and Quantitative Data Analysis
      Ronald Boellaard
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 11S-20S; DOI: https://doi.org/10.2967/jnumed.108.057182

C

  1. Contractor, Kaiyumars B.

    1. You have access
      Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
      Kaiyumars B. Contractor and Eric O. Aboagye
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 97S-105S; DOI: https://doi.org/10.2967/jnumed.108.057273

D

  1. de Geus-Oei, Lioe-Fee

    1. You have access
      Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224
  2. Dehdashti, Farrokh

    1. You have access
      The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257
  3. Delbeke, Dominique

    1. You have access
      The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257
  4. Dunphy, Mark P.S.

    1. You have access
      Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
      Mark P.S. Dunphy and Jason S. Lewis
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 106S-121S; DOI: https://doi.org/10.2967/jnumed.108.057281

F

  1. Fury, Matthew

    1. You have access
      PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208

G

  1. Grigsby, Perry W.

    1. You have access
      The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

H

  1. Herrmann, Ken

    1. You have access
      18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232
  2. Hicks, Rodney J.

    1. You have access
      Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer
      Rodney J. Hicks
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 31S-42S; DOI: https://doi.org/10.2967/jnumed.108.057216
  3. Hutchings, Martin

    1. You have access
      PET/CT for Therapy Response Assessment in Lymphoma
      Martin Hutchings and Sally F. Barrington
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 21S-30S; DOI: https://doi.org/10.2967/jnumed.108.057190

J

  1. Jacene, Heather

    1. You have access
      From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

K

  1. Kasamon, Yvette

    1. You have access
      From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307
  2. Kraus, Dennis

    1. You have access
      PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208
  3. Krause, Bernd J.

    1. You have access
      18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232

L

  1. Lee, Nancy

    1. You have access
      PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208
  2. Lewis, Jason S.

    1. You have access
      Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
      Mark P.S. Dunphy and Jason S. Lewis
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 106S-121S; DOI: https://doi.org/10.2967/jnumed.108.057281
  3. Lodge, Martin A.

    1. You have access
      From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307

O

  1. Oyen, Wim J.G.

    1. You have access
      Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

R

  1. Roylance, Rebecca

    1. You have access
      Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240

S

  1. Sassen, Stefanie

    1. You have access
      Response to Therapy in Breast Cancer
      Norbert Avril, Stefanie Sassen and Rebecca Roylance
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 55S-63S; DOI: https://doi.org/10.2967/jnumed.108.057240
  2. Schöder, Heiko

    1. You have access
      PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
      Heiko Schöder, Matthew Fury, Nancy Lee and Dennis Kraus
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 74S-88S; DOI: https://doi.org/10.2967/jnumed.108.057208
  3. Schwarz, Julie K.

    1. You have access
      The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries
      Julie K. Schwarz, Perry W. Grigsby, Farrokh Dehdashti and Dominique Delbeke
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 64S-73S; DOI: https://doi.org/10.2967/jnumed.108.057257

V

  1. van der Graaf, Winette T.A.

    1. You have access
      Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224
  2. van Laarhoven, Hanneke W.M.

    1. You have access
      Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224
  3. Vriens, Dennis

    1. You have access
      Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review
      Lioe-Fee de Geus-Oei, Dennis Vriens, Hanneke W.M. van Laarhoven, Winette T.A. van der Graaf and Wim J.G. Oyen
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 43S-54S; DOI: https://doi.org/10.2967/jnumed.108.057224

W

  1. Wahl, Richard L.

    1. You have access
      From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
      Richard L. Wahl, Heather Jacene, Yvette Kasamon and Martin A. Lodge
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 122S-150S; DOI: https://doi.org/10.2967/jnumed.108.057307
  2. Weber, Wolfgang A.

    1. You have access
      Assessing Tumor Response to Therapy
      Wolfgang A. Weber
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 1S-10S; DOI: https://doi.org/10.2967/jnumed.108.057174
  3. Wieder, Hinrich

    1. You have access
      18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232

Z

  1. zum Büschenfelde, Christian Meyer

    1. You have access
      18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
      Bernd J. Krause, Ken Herrmann, Hinrich Wieder and Christian Meyer zum Büschenfelde
      Journal of Nuclear Medicine May 1, 2009, 50 (Suppl 1) 89S-96S; DOI: https://doi.org/10.2967/jnumed.108.057232
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 50 (Suppl 1)
Journal of Nuclear Medicine
Vol. 50, Issue Suppl 1
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire